t+ Medical, the UK-based company that supplies mobile phone-based technology for capturing patient data in long-term condition management and clinical trials, has widened its palette of services by acquiring telecare specialist Vivatec.

Terms of the deal were not disclosed. According to the companies, it creates “a complete solution for both healthcare and drug discovery organisations”. Last year t+ Medical set up a dedicated subdidiary, t+ Clinical, to market data-capture solutions for late-stage clinical trials to pharmaceutical clients.

t+ Medical said the acquisition would allow it to expand aggressively by offering an integrated solution encompassing medical devices, communications technology and nurse call centres.

“The synergy between the two companies provides an ideal base from which to further deliver the benefits of mobile telephones in healthcare and we expect that this latest development will enable the rapid growth that we have experienced to continue,” commented Tim Clover, chief executive officer of t+ Medical Holdings and Andrew Hall, founder and managing director of Vivatec, in a joint statement.

Formerly based in Wokingham, UK, Vivatec specialises in ‘preventative telecare’ – that is, products and services designed to help older people live independently at home. These range from pill dispensers and alarm systems to wellness data and alerts that can be sent over the telephone to a central computer.

As t+ Medical noted, Vivatec is one of only 13 companies to be selected as a supply partner to the National Health Service Purchasing and Supply Agency. The company supplies two of the three Department of Health-funded Whole System Demonstrators that are evaluating remote monitoring technologies across 6,000 patients in the UK.